Telehealth Use Across Time and Regional Medical Resources During the COVID-19 Pandemic: Evidence from China.

Introduction: The coronavirus disease 2019 (COVID-19) pandemic has created lots of difficulties for individuals to seek medical help offline. Telehealth is considered as a potential approach to solve this issue. During the COVID-19 pandemic, although the use of telehealth has increased in the short term, it still remains unknown whether the use of telehealth can maintain a high level of development in the long term. The purpose of this article is to investigate the impact of COVID-19 pandemic on telehealth use across time and regional medical resources. Materials and Methods: Our research used the Internet search index from Baidu Index Platform in 31 provinces of China as the proxy of telehealth use. A total of 2,119,486 times of searching behaviors from January 2018 to December 2021 are included in our dataset. Changing plots, the method of analysis of variance and empirical models are applied to reveal the relationship between COVID-19 pandemic and telehealth use. Results: Baidu Index counts increased (p < 0.01) at the beginning of COVID-19 pandemic (2020) but started to decline (p < 0.01) during the period of regular epidemic prevention and control (2021). Moreover, the counts of Baidu Index in regions with rich medical resources are higher than those in other regions in 2020. Comparing Baidu Index counts in 2020, the COVID-19 pandemic has higher positive effects on telehealth use during the period of 2021 in regions with average and poor medical resources. Conclusions: COVID-19 pandemic has a positive effect on telehealth use in 2020 but has a negative effect in 2021. During the epidemic, telehealth use differs in regions with rich, average, and poor medical resources. Our findings indicate that the use of telehealth should be promoted with different measures in regions with different medical resources, thereby contributing its healthy development in the long term.

Polyphenylene sulfide fabric with improved antibacterial properties and comprehensive performances by new polybenzoxazine based coating for protection applications

Polyphenylene sulfide (PPS) fabric is promising for personal protective equipment (PPE) due to its excellent mechanical properties. However, issues such as a lack of antibacterial properties, limits its applications, especially today when COVID-19 is a pandemic. Herein, we synthesize a new benzoxazine monomer (BTE) with ester and triazole groups and demonstrate its usage as a coating for comprehensive high-performance PPS fabric. The polymerized BTE exhibits an antibacterial rate of 77.4%, and outstanding flame-retardant properties (The Heat release capacity (HRC) value is 62 J g−1 K−1 and the Total heat release (THR) value is 9.4 kJ g−1). The mechanical performance and acid resistance of BTE-coated PPS fabric show excellent improvement. The tensile strength of the modified system rise by approximately 24.7%, reaching 8.6 MPa, while the corresponding Young's modulus increases by 51.7%, reaching 36.7 MPa, respectively, and after 72 h of acid treatment, the tensile strength retention rate reaches 91.7%. Furthermore, the BTE-coated PPS fabric demonstrates a complete change in wettability (the hydrophilic surface of PPS becomes hydrophobic for BTE-coated PPS) with only a slight reduction in the air permeability (260 mm s−1 for PPS and 198 mm s−1 for BTE coated PPS), making it an appealing material for PPE and demonstrating the potential of related materials for harsh environment protective systems.

Impacts of COVID-19 pandemic on the aquatic environment associated with disinfection byproducts and pharmaceuticals.

In this study, concentrations of disinfection byproducts (DBPs) and COVID-19 related pharmaceuticals in wastewater effluents and surface water were measured two weeks, three months and eight months after the lockdown in Wuhan. Little temporal variation in DBP concentrations suggested intensified disinfection during the COVID-19 pandemic had limited impacts on the occurrence of DBPs in the aquatic environment. In contrast, the pandemic led to a significant increase in concentrations of lopinavir and ritonavir in wastewater effluents and surface water. The high detection frequency of these pharmaceuticals in surface water after the lockdown highlighted their mobility and persistence in the aquatic environment. The initial ecological risk assessment indicated moderate risks associated with these pharmaceuticals in surface water. As the global situation is still rapidly evolving with a continuous surge in the number of confirmed COVID-19 cases, our results suggest a pressing need for monitoring COVID-19 related pharmaceuticals as well as a systematic evaluation of their ecotoxicities in the aquatic environment.

Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019.

Coronavirus disease 2019 (COVID-19) was initially regarded as a disease of the lungs, which manifests as an acute respiratory illness and pneumonia, although more recently cardiac complications have been well-characterised. Serological cardiac biomarkers have been used to define acute myocardial injury, with significant elevation of high-sensitivity cardiac troponin (hs-cTn) associated with poor prognosis. Accordingly, 20-25% patients with acute myocardial injury (as defined by an elevated hs-cTn greater than the 99th percentile) have clinical signs of heart failure and increased mortality. An important outstanding clinical question is how best to determine the extent and nature of cardiac involvement in COVID-19. Non-invasive cardiac imaging has a well-established role in assessing cardiac structure and function in a wide range of cardiac diseases. It offers the potential to differentiate between direct and indirect COVID-19 effects upon the heart, providing incremental diagnostic and prognostic utility beyond the information yielded by elevated cardiac biomarkers in isolation. This review will focus on the non-invasive imaging assessment of cardiac involvement in COVID-19.

Exploration on the emergency support mode of hospital medical supplies under the epidemic of NCP / 中华医院管理杂志

Since the outbreak of Novel Coronavirus Pneumonia(NCP), hospitals have taken the fight against the virus as its own responsibility, and keep standing in the front line of epidemic prevention and control. The continuous input of anti-epidemic forces in hospitals also brings challenges to the medical supplies support, including the management of protective supplies and the maintenance of medical equipment. In the face of increasing security pressure, the medical materials support team broke the game on multiple fronts. Firstly, the team implements active material procurement strategy, sets material distribution priority according to risk level, releases materials uniformly based on stock and use, and implements traceability management of donated materials to ensure material supply. Secondly, centralized allocation management of equipment, emergency installation, advanced maintenance and emergency maintenance work is effectively completed. Thirdly, disinfection strategies for items and equipment are developed safely and effectively with the aid of disinfection equipment functions. At last, personnel management and training have been strengthened. These measures have provided strong support for the orderly prevention and control of the epidemic.